So-Young International Inc.
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Xing Jin
- Full Time Employees
- 1,800
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Ronsin Technology Center Beijing People's Republic of China 100102
- IPO Date
- May 2, 2019
- CIK
- 0001758530
- Website
- soyoung.com
- Similar Companies
- Business
- So-Young International Inc. (Nasdaq: SY) operates as the leading aesthetic treatment platform in China, connecting consumers with online services and offline treatments through its digital ecosystem and branded aesthetic centers. Founded in 2013 and headquartered in Beijing, the company offers curated treatment information, user-generated content via Beauty Diaries and reviews, online reservations, high-quality aesthetic treatments including non-invasive procedures such as thread lifts, intense pulsed light, ultrasound facelifts, picosecond lasers, body contouring, and injectables like skin boosters, hyaluronic acid-based products, botox, and collagen; research, development, production, sale, and distribution of optoelectronic medical equipment encompassing excimer laser systems, UV excimer therapy devices, LED and red-light therapy systems, surgical lasers, hydrodynamic-assisted liposuction systems, and pneumatic liquid spray devices; sales of injectable products; maintenance, installation, operational training, and equipment packaging services; consumption healthcare services in dermatology, dentistry, orthodontics, gynecology, postnatal care, ophthalmology, and physical examinations; and content management through short-form videos, featured articles, and chat messages. So-Young primarily serves consumers and medical aesthetic service providers in China across ten major cities including Beijing, Shanghai, Guangzhou, Shenzhen, Hangzhou, Chengdu, Wuhan, Chongqing, Ningbo, and Changsha, leveraging its social community, key opinion leader networks, partnerships with platforms like Meituan, and exclusive distribution rights for treatments such as BBL to drive user engagement and blockbuster product penetration exceeding 30% of revenues. In recent developments, the company expanded its branded aesthetic centers to 39 fully operational locations (38 directly-operated, 1 franchised) by September 30, 2025, with 20 achieving profitability and 29 generating positive quarterly operating cash flow; reported third-quarter 2025 aesthetic treatment services revenues of RMB183.6 million, a 304.6% increase year-over-year, surpassing guidance; grew verified treatment visits to over 89,800 and active users exceeding 130,000; increased core members by over 10,000 sequentially with 88% revenue contribution and 70% repurchase rate; regained Nasdaq minimum bid price compliance in July 2025; announced and extended plans for an ADS ratio change in May and June 2025; and targets at least 35 new centers in 2026 alongside Q4 2025 aesthetic treatment services revenues between RMB216 million and RMB226 million, emphasizing digitalization, AI enhancements, supply chain synergies, and customer acquisition efficiency with 46% from referrals.
So-Young: Revenue Acceleration Is Overshadowed By Widening Losses (Rating Downgrade)
So-Young International Inc. (SY) Q1 2026 Earnings Call Transcript
So-Young International Q1 Earnings Call Highlights
So-Young Reports Unaudited First Quarter 2026 Financial Results
So-Young to Report First Quarter 2026 Financial Results on May 22, 2026
So-Young to Report First Quarter 2026 Financial Results on May 22, 2026
So-Young International Inc. Files Its Annual Report on Form 20-F
So-Young International Q4 Earnings Call Highlights
So-Young International Inc. (SY) Q4 2025 Earnings Call Transcript
So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2025 Financial Results
So-Young to Report Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026
Head-To-Head Review: So-Young International (NASDAQ:SY) and CVS Health (NYSE:CVS)
Citigroup Inc. Purchases 626,963 Shares of So-Young International Inc. Sponsored ADR $SY
So-Young International Inc. (SY) Q3 2025 Earnings Call Transcript
So-Young Reports Unaudited Third Quarter 2025 Financial Results
So-Young to Report Third Quarter 2025 Financial Results on November 17, 2025
So-Young: Turning Positive On Sales Beat And Attractive Valuations (Rating Upgrade)
So-Young International Inc. (SY) Q2 2025 Earnings Call Transcript
So-Young Reports Unaudited Second Quarter 2025 Financial Results
So-Young to Report Second Quarter 2025 Financial Results on August 15, 2025